zation. Overall 11 (46%) cranial nerve symptoms showed complete resolution, eight (33%) showed some improvement, and five (21%) were unchanged. In three cases (12.5%), the symptoms worsened after treatment. The shorter the duration of symptoms was a factor predisposing to resolution of symptoms. In complete resolution cases, the timing of treatment after symptoms appeared and the time of complete resolution were in proportion.
Introduction
The standard treatment of patients with aneurysms causing cranial nerve palsy has been direct surgery [1] [2] [3] . Since this is difficult to perform for cavernous portion internal carotid artery aneurysms, endovascular surgery may be needed for such cases.
However, endovascular treatment of unruptured aneurysms causing mass effects on cranial nerves is still controversial [4] [5] [6] . The present study was conducted to evaluate its efficacy for a series of internal carotid artery aneurysms with cranial nerve palsy.
Summary
Whether endovascular surgery is able to reduce the mass effects of unruptured aneurysms is still controversial, although some reports have suggested efficacy in cases of internal carotid artery aneurysms with cranial nerve palsy. Here we assessed outcome in a series of cases.
Between April 1992 and April 2005, 18 patients with unruptured internal carotid artery aneurysms presenting with cranial nerve palsy were treated by endovascular surgery. The patients were two males and 16 females aged from 19 to 84 (mean 59.6 years). Aneurysms were located in the cavernous portion in 14, at the origin of the ophthalmic artery in one and at the origin of P-com in three. The aneurysms were all embolized using Guglielmi detachable coils, Interlocking detachable coils, Cook's detachable coils or Trufill DSC and detachable Balloons were applied to occlude the proximal parent artery. We analyzed the efficacy of endovascular surgery for such aneurysms retrospectively.
The mean aneurysm size was 21.4 mm and the mean follow-up period was 57.7 months. Palsy of II nd cranial nerve was evident in three patients, of the III rd in eight, of the V th and V th in one each, and of the VI th in nine. Post embolization occlusion was complete in nine patients and neck remnant in the other seven.
Regarding complications of endovascular surgery, one case (5.6%) showed TIA after emboli-
Material and Methods
Between April 1992 and April 2005, 18 patients with unruptured internal carotid artery aneurysms with cranial nerve palsy were treated by endovascular surgery in our institution. All were retrospectively examined for their clinical symptoms over time for analysis of efficacy. The patients were two males and 16 females aged from 19 to 84 (mean 60.6 years). The aneurysms were located in the cavernous portion in 14, at the origin of ophthalmic artery in one and at the origin of P-com in three. Embolization was performed under focal anesthesia after systemic heparinisation with a bolus of 2000 IU, followed by continuous injection of 200 IU/min and maintenance of an activated coagulation time (ACT) more than twice the control value. A microcatheter (Excelsior, Excel 14 or SL-10; Boston Scientific, Natick, Massachusetts) was carefully inserted into the aneurysm with the guidewire and embolization was achieved using Guglielmi detachable coils (GDC; Boston Scientific, Natick, Massachusetts), interlocking detachable coils (IDC; Boston Scientific, Natick, Massachusetts), Cook's detachable coils (CDC; Cook Inc.), Trufill DCS (Johnson & Johnson) or detachable balloon occluded proximal parent artery. Post embolization, anti-platelet therapy using aspirin was started, and continued for six months. The following cranial nerve symptoms and signs were evaluated and all patients were followed by MRA and thin slice MRI.
Results
Our patient details are summarized in table 1. The mean aneurysm size was 21.4 mm (range 5 to 40 mm). Three patients had palsy of the II, eight of the III, one each of the IV and V, and nine of the VI cranial nerve. The timing of treatment by endovascular surgery was a mean of 176.9 days after the initial symptoms appeared. The mean follow-up period was 57.7 months. Post-embolization occlusion was complete in nine patients and seven had neck remnants. The final occlusion results were complete in 14 patients and neck remnant in the remaining four.
Overall, 11 (46%) cranial nerve symptoms showed complete resolution, eight (33%) symptoms showed some improvement, and five (21%) symptoms were unchanged. However, in three cases (12.5%), symptoms worsened temporarily after treatment. In complete resolution cases, the aneurysm mean size was 19.6 mm (range 10 mm to 40 mm) and the mean followup period was 71.1 months (table 2). The timing of treatment in these cases was 140.2 days (mean), and the time to complete resolution was 137.6 days (mean) (table 2). In partial improvement cases, aneurysm mean size was 18.4 mm (range 5 mm to 35 mm) and the mean follow-up period was 38.2 months (table 2) . The timing to treatment in these cases was 125.5 days (mean) (table 2). In unchanged cases, aneurysm mean size was 27 mm (range 15 mm Figure 1 The relationship of the timing to treatment and change in symptoms. The shorter the period before treatment is the most important factor for better resolution. figure 1 . The shorter the period for treatment is the most important factor for better resolution. In those where this was complete, the timing to treatment after symptoms appeared and the time for resolution were in proportion (figure 2). The complete resolution rates for CN symptoms were 50% for optic nerves, 44% for III, 100% for IV, 100% for V and 33% for VI cranial nerves (table 3). In intracranial aneurysm cases, the mean size was 12.5 mm. These cases showed complete resolution of CN symptoms in 25%, and some improvement in 75% (table  4 ). In extradural aneurysm cases, these mean size was 23.9 mm, complete resolution of CN symptoms was found in 50%, some improve-ment in 25% and no change in 25% (table 4) . Regarding complications of endovascular surgery in our cases, one (5.6%) showed TIA after embolization.
Discussion
Generally surgical clipping for intracranial aneurysms with mass effect symptoms has advantages with regard to reduction of the mass effect for cranial nerves compared with endovascular surgery. In a published report of clipping surgery for unruptured aneurysms, Drake et Al 10 Figure 2 The relationship of the timing to treatment after symptoms appeared and the timing for resolution in complete resolution cases. The period of complete resolution of cranial nerve deficits is in proportion to the timing to treatment after symptoms appeared.
Case
Size (table 5) . However, cavernous portion internal carotid artery aneurysms are very difficult to treat by clipping and therefore recently interest has therefore focused on reports that endovascular surgery for aneurysm with mass effect is effective because of reduction of aneurysm size after endosacular embolization 4, 5 . These reports and our present results indicate that there is no difference in rates of reduction of the mass effect between surgical clipping and endovascular surgery. Furthermore, endovascular treatment for aneurysms with mass effects by endosaccular embolization has also been described 1, 2, 7 .
What factors influence outcome of endovascular surgery? Halbach et Al 4 emphasized detrimental effects of a long duration of symptoms such as calcification of aneurysm walls. Malish et Al 3 , in contrast, reported small size of aneurysm and short duration to be positive factors. Kazekawa et Al 8 found cases treated within 12 months of initial symptom to have good outcomes. In our patients, the times to treatment after symptoms appeared was 140.2 days in complete resolution cases, 125.5 days in partial improvement cases and 526.2 days in unchanged cases. The aneurysm mean sizes were 19.6, 18.4 and 27 mm, respectively.
Is the location of an aneurysm related to results of endovascular surgery? Kim et Al 6 reported showed better improvement or resolution with intradural as opposed to extradural aneurysms. In our cases, all intracranial cases showed improvement or resolution, whereas resolution was complete in 50% of extradural aneurysm cases but no change resulted in 25%.
One reason for poor results is that extradural aneurysms exhibit symptoms very slowly, so the duration of pressure on cranial nerves is long. Endovascular treatment for ICPC aneurysms allowed complete resolution in 80% of series described by Miyachi et Al in a text- Table 4 The comparision of clinical data and resuls for treatment of intradural or extradural aneurysm. book. These aneurysms cause CN symptoms from early stages, and therefore tend to be treated immediately. In contrast, results for optic nerve disorders with paraclinoid aneurysms are less positive. Thornton et Al 12 reported six cases, in only two of which was resolution complete and 38% patients became blind after treatment. Upper and upper-inside type ophthalmic and carotid anterior wall type aneurysms have high optic nerve disorder rates, and symptoms frequently worsen after treatment. Malish et Al 3 found many patients with ophthalmic aneurysms to need re-treatment, and discussed three reasons for poor results. The first is that optic symptoms appear very slowly. The second is that the pressure point is near the optic canal so the space of nerve decompression is very narrow. The last is that ischemic complications for optic nerves may be caused by endovascular treatment. In our se-ries, three cases had temporary worsening of symptoms after embolization. From basic research, the aneurysms may enlargement temporarily after endosaccular embolization. However, in our cases the volumes of aneurysms were reduced after one month.
Conclusions
The present results indicated that there may be no differences in rates for reduction of mass effects between surgical clipping and endovascular surgery for cases of unruptured internal carotid artery aneurysms presenting with cranial nerve symptoms. With endovascular surgery, rapidity of treatment after symptoms appear is the most important factor for successful results. In future, covered stent therapy might be substituted for endovascular coil embolization for these aneurysms.
